Trial Profile
Effect of plerixafor in multiple myeloma patients for stem cell mobilisation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Granulocyte colony-stimulating factors; Lenalidomide
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 21 Dec 2015 New trial record